Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve Unlimited fulltext viewing of this article Organize, annotate And mark up articles Printing And downloading restrictions apply

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: August 31, 2021
Accepted: July 13, 2022
Published online: December 13, 2022

Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 5

ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)

For additional information: https://www.karger.com/ORL

Abstract

Introduction: The standard complete evaluation of patients with head and neck squamous cell carcinoma (HNSCC) has included a staging exam under anesthesia (EUA) since the 1970s. The EUA for all sites of HNSCC has historically consisted of panendoscopy for the purpose of diagnostic biopsy, accurate staging of primary disease, and identification of second primary tumors. However, due to the accessibility of the oral cavity, the sole purpose of EUA for tumors of this site is to identify second primary tumors. Since the EUA became the gold standard for evaluation of HNSCC, there have been significant advancements in less invasive technologies such as CT, PET-CT, MRI, and fiberoptic examination. In this study, we sought to determine the value to patient care and cost-effectiveness of EUA in patients with oral cavity squamous cell carcinoma (OCSCC). Methods: A retrospective chart review identified 77 patients who underwent EUA for OCSCC. Results: The most common subsites were the oral tongue and floor of mouth (59.7% and 24.7% respectively). All underwent direct laryngoscopy, 94.8% underwent esophagoscopy, and 20.8% underwent flexible transnasal examination in clinic prior to EUA. For 90.9% of patients, the EUA did not change initial T-staging based on clinical examination and imaging. The remaining 9.1% of patients were upstaged after EUA, however this change did not impact the treatment plan. Second primary tumors were identified in 3.9% of patients, all were found in either the oral cavity or oropharynx, and were also identified with clinical examination or imaging. Analysis of patient charges determined an average cost of $8,022.93 per patient under the current paradigm involving EUA, however with a new algorithm eliminating mandatory EUA average cost decreases to $1,448.44. Conclusion: Formal EUA has historically been the gold standard for all HNSCC tumors. However, when performed for cases of oral cavity carcinoma, it is safe and cost effective to limit its use to select clinical scenarios.

© 2022 S. Karger AG, Basel

References McGuirt WF. Panendoscopy as a screening examination for simultaneous primary tumors in head and neck cancer: a prospective sequential study and review of the literature. Laryngoscope. 1982;92(5):569–76. Leipzig B, Zellmer JE, Klug D. The role of endoscopy in evaluating patients with head and neck cancer. A multi-institutional prospective study. Arch Otolaryngol. 1985;111(9):589–94. Norris CM. Current developments in bronchoscopy. The role of the flexible fiberscope. J Otolaryngol. 1976;5(3):193–202. Parker JT, Hill JH. Panendoscopy in screening for synchronous primary malignancies. Laryngoscope. 1988;98(2):147–9. Benninger MS, Enrique RR, Nichols RD. Symptom-directed selective endoscopy and cost containment for evaluation of head and neck cancer. Head Neck. 1993;15(6):532–6. Rodriguez-Bruno K, Ali MJ, Wang SJ. Role of panendoscopy to identify synchronous second primary malignancies in patients with oral cavity and oropharyngeal squamous cell carcinoma. Head Neck. 2011;33(7):949–53. Erkal HS, Mendenhall WM, Amdur RJ, Villaret DB, Stringer SP. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. J Clin Oncol. 2001;19(5):1358–62. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6(5):963–8. Guardiola E, Pivot X, Dassonville O, Poissonnet G, Marcy P-Y, Otto J, et al. Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan? Cancer. 2004;101(9):2028–33. Guardiola E, Chaigneau L, Villanueva C, Pivot X. Is there still a role for triple endoscopy as part of staging for head and neck cancer? Curr Opin Otolaryngol Head Neck Surg. 2006;14(2):85–8. Shaha AR, Hoover EL, Mitrani M, Marti JR, Krespi YP. Synchronicity, multicentricity, and metachronicity of head and neck cancer. Head Neck Surg. 1988;10(4):225–8. Davidson J, Gilbert R, Irish J, Witterick I, Brown D, Birt D, et al. The role of panendoscopy in the management of mucosal head and neck malignancy-a prospective evaluation. Head Neck. 2000;22(5):449–54; discussion 454–5. Su WW-Y, Chuang S-L, Yen AM-F, Chen SL-S, Fann JC-Y, Chiu SY-H, et al. Risk for a second primary hypopharyngeal and esophageal cancer after an initial primary oral cancer. Oral Dis. 2019;25(4):1067–75. Di Martino E, Nowak B, Hassan HA, Hausmann R, Adam G, Buell U, et al. Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg. 2000;126(12):1457–61. Tsao GJ, Damrose EJ. Complications of esophagoscopy in an academic training program. Otolaryngol Head Neck Surg. 2010;142(4):500–4. McGarey PO, Jr, O’Rourke AK, Owen SR, Shonka DC Jr, Reibel JF, Levine PA, et al. Rigid esophagoscopy for head and neck cancer staging and the incidence of synchronous esophageal malignant neoplasms. JAMA Otolaryngol Head Neck Surg. 2016;142(1):40–5. Wind P, Roullet MH, Douard R, Laccoureye O, Brasnu D, Cugnenc PH. Experience in the treatment of synchronous and metachronous carcinoma of the oesophagus and the head and neck. J Surg Oncol. 2000;73(3):138–42. Nikolaou AC, Markou CD, Petridis DG, Daniilidis IC. Second primary neoplasms in patients with laryngeal carcinoma: second primary neoplasms in patients with laryngeal carcinoma. Laryngoscope. 2000;110(1):58–64. Kerawala CJ, Bisase B, Lee J. The use of examination under anaesthesia and panendoscopy in patients presenting with oral cavity and oropharyngeal squamous cell carcinoma. Ann R Coll Surg Engl. 2009;91(7):609–12. Koo K, Harris R, Wiesenfeld D, Iseli TA. A role for panendoscopy? Second primary tumour in early stage squamous cell carcinoma of the oral tongue. J Laryngol Otol. 2015;129(S1):S27–31. Noor A, Stepan L, Kao SS-T, Dharmawardana N, Ooi EH, Hodge J-C, et al. Reviewing indications for panendoscopy in the investigation of head and neck squamous cell carcinoma. J Laryngol Otol. 2018;132(10):901–5. Metzger K, Horn D, Pfeiffer T, Moratin J, Kansy K, Ristow O, et al. Is panendoscopy a necessary staging procedure in patients with lacking risk factors and oral squamous cell carcinoma? J Craniomaxillofacial Surg. 2019;47(12):1968–72. Valentin A, Goetz M, Hetzel J, Reinert S, Hoefert S. Routine panendoscopy in oral squamous cell cancer patients: mandatory or facultative? Clin Oral Investig. 2021;25(3):1245–54. Koerdt S, Raguse J-D, Neumann F, Beck-Broichsitter B, Kreutzer K, Neumann K, et al. Value of panendoscopy in the identification of synchronous malignancies in patients suffering from oral squamous cell carcinoma without clinical signs of a second primary tumor. Anticancer Res. 2021;41(4):2039–44. Stokkel MP, Moons KG, ten Broek FW, van Rijk PP, Hordijk GJ. 18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer. 1999;86(11):2370–7. Article / Publication Details

First-Page Preview

Received: August 31, 2021
Accepted: July 13, 2022
Published online: December 13, 2022

Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 5

ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)

For additional information: https://www.karger.com/ORL